Introduction
NK cells and some T cells express members of a multigenic family of killer cell Ig-like receptors (KIRs) 3 that recognize polymorphic class I MHC molecules on target cells (reviewed in refs. [1] [2] [3] [4] . Both natural cytotoxicity and antibody dependent cell cytotoxicity of NK cells, and CD3/TCR dependent cytotoxicity of T cells are inhibited by the coengagement of KIRs and activating receptors such as FcR and TCR (5) (6) (7) (8) . Recent studies have suggested that KIR plays a role in the survival of memory-phenotype T cells (9, 10) and in the inhibition of T cell activation induced cell death (AICD) (9, 11, 12) . However, the exact mechanism of the AICD inhibition mediated by KIR has not been revealed yet. Inhibitory KIRs (KIR hereafter) are type I transmembrane glycoproteins belonging to the Ig superfamily and consist of either two (for p58 KIR and KIR103: KIR2D family) or three (for p70 KIR: KIR3D family) extracellular Ig-related domains, a transmembrane part and a cytoplasmic tail (13) (14) (15) (16) . The extracellular domain of KIR specifically recognizes particular class I MHC molecules expressed on target cells (17) (18) (19) (20) . The cytoplasmic tail of KIR contains either one (for KIR103) or two (for p58 and p70 KIR) immunoreceptor tyrosine-based inhibition motifs (ITIMs) that function in triggering an inhibitory signal transduction that, in turn, prevents killer cell-mediated cytotoxicity (21) (22) (23) (24) . The ITIM, which has the consensus sequence of (I/V) xYxx (L/V), was originally found in the cytoplasmic tail of Fc RIIB (25, 26) . Fc RIIB has also been shown to transmit the inhibitory signals in B cell activation by recruitment of SH2-containing inositol phosphatase (SHIP) upon tyrosine phosphorylation of the ITIM (25, 27, 28) . The consensus sequence of ITIM is similar but clearly distinguishable from the immunoreceptor tyrosine-based activation motif (ITAM) found in the signaling molecules associated with several lymphocyte antigen receptors (29, 30) .
Upon engagement of KIR, tyrosine residues in
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Hyun Il Cho 1 ITIMs are phosphorylated by a src-family protein tyrosine kinase (like p56 Lck), and in turn a SH2-containing protein tyrosine phosphatase (SHP), SHP-1, is recruited to the phosphotyrosyl residues (21) (22) (23) (24) 31) . It has also been shown that another SHP, SHP-2 (31, 32) , and the p85 regulatory subunit of phosphatidylinositol (PI) 3-kinase (32) are recruited to the phosphotyrosyl residues of KIR. The functional importance of SHP-1 in the KIR-mediated inhibition of NK cell activation is further supported by the observation that the overexpression of a dominant negative form of SHP-1 reverses the inhibitory effect of KIR (21, 22) . It is thought that the inhibitory effect of KIR results from the dephosphorylation of phospho-tyrosine residues in signaling molecules involved in the activating signal transduction pathway by SHP (SHP-1 or SHP-2) recruited to the KIR. For FcR-mediated ADCC of NK cells, Binstadt et al. (21) reported that coengagement of FcR and KIR inhibited the phosphorylation of FcR-associated signaling molecules including TCR , ZAP-70 and PLC-. Similarly, when , ZAP-70, and Lck were coexpressed with SHP-1 in Sf21 insect cells, the levels of tyrosine phosphorylation in these molecules decreased substantially (33) . It has also been demonstrated that class I MHC recognition by KIR blocks the formation of a complex between tyrosine-phosphorylated pp36 (LAT) and PLC-in human NK cells (34) . And Binstadt et al. have demonstrated that the SH2-containing leukocyte protein 76 (SLP-76) may be a specific target for dephosphorylation by SHP-1 in T cells and NK cells (35) . These results suggest that SHP recruited to KIR may dephosphorylate those signaling molecules in NK cells and T cells.
Shc is an adaptor protein composed of a unique N-terminal phospho-tyrosine binding domain (PTB), a glycine/proline-rich collagen homology domain (CH) and a C-terminal SH2 domain (36) (37) (38) . Shc is ubiquitously expressed in three isoforms of 46, 52, and 66 kDa, but only the 46 and 52 kDa forms are present in hematopoietic cells (36) . Shc has been implicated in Ras activation triggered by a number of receptors, including growth factor receptors, antigen receptors and cytokine receptors (reviewed in refs. 39, 40) . The SH2 and PTB domains of Shc have been shown to interact with the tyrosine phosphorylated receptors. Shc is tyrosine phosphorylated upon stimulation of the receptors and subsequently it interacts with Grb2 through the CH domain. The Shc Grb2 complex, in turn, associates with the GTP/GDP exchange factor, SOS, and finally leads to Ras activation. Shc can also activate the Akt pathway via Shc-Grb2-Gab2-PI3K (phosphatidylinositol 3-kinase) in B cells (41) .
In this report, by in vitro coprecipitation experiments and transfection analyses, we showed that KIR associates with an adaptor protein Shc in resting cells. We further demonstrated that Shc is replaced by SHP upon engagement of KIR by antibody. Antibodies and other reagents. Anti-phospho tyrosine antibody (PY20), anti-SHP-1, anti-SHP-2, anti-Grb2 and anti-Shc antibodies were purchased from Transduction Laboratories (Lexington, KY). Fluorescein isothiocyanate (FITC) conjugated anti-mouse IgG and Texas-red conjugated anti-rabbit IgG were obtained from Vector Laboratories (Burlingamme, CA), and PE-conjugated anti-mouse IgG and anti-CD8 antibodies were from Beckton Dickinson (San Jose, CA). Dithiobissuccinimidyl propionate (DSP) was purchased from Pierce (Rockford, IL). Ni-NTA resin was obtained from Qiagen (Santa Clarita, CA), and protein A-agarose and protein G-agarose were from Boeringer Manheim (Indianapolis, IN). cDNA of a p70 KIR (NKB1) was a kind gift from Dr. Lanier (DNAX Research Inst., Palo Alto, CA). Polyclonal antibodies to the cytoplasmic tail of KIR were produced in mice using the bacterially expressed His-tag fusion protein of KIR (His-CytKIR; refs. 42, 43) . Briefly, the His-CytKIR protein was further purified on SDS polyacrylamide gels and the protein band was excised with a scalpel. The gel slices were homogenized and injected into mice intraperitoneally. A booster injection was given 2 weeks after the primary immunization. Another two booster injections were given every two weeks, and the animals were bled 2 weeks later. His-tag and CD8 fusion constructs of KIR cytoplasmic tail, and other DNA constructs. The His-tag fusion protein construct of a p70 KIR (NKB1; ref. 14) cytoplasmic tail (pHis-CytKIR) was described previously (42, 43) , and the generation of plasmid containing the extracellular and transmembrane portion of CD8 , pCD 8T, was also described previously (44) . A CD8 fusion construct of KIR cytoplasmic tail was generated by subcloning the cytoplasmic tail of NKB1 into the pCD8T. Briefly, the cytoplasmic tail of NKB1 was amplified by PCR with primers 5'-GGGGAATTCC ATCTCTGGTGCTCCAACAAAAAAAAT-3' and 5'-GGGGGATCCTCATGGGCAGGAGACAACTTT GG-3'. The amplified DNAs were cloned into EcoRI and BamHI sites of pBluscript (Strategene, La Jolla, CA) and verified by nucleotide sequencing. Then the KIR cytoplasmic fragment was inserted in frame into the EcoRI sites of pCD8T. The resulting chimeric receptor (CD8-KIR) was excised from the plasmid and ligated into SalI and BamHI sites of the eucaryotic expression vector, pH APr-1-neo (45) .
Materials and Methods

Cell
Metabolic labeling of Jurkat T cells/Preparation of cell lysates.
Jurkat cells (5×10 6 cells) were washed with 10 ml of methionine-free RPMI 1640 and preincubated for 1 hr in 10 ml of methionine-free RPMI 1640 supplemented with 10% heat-inactivated dialyzed FBS. Cells were then incubated in the presence of 100 Ci/ml L-[ 35 S]methionine at 37 o C for 2 hr. After labeling, the cells were washed two times with cold PBS, and lysed in 0.5 ml of cold lysis buffer containing 20 mM Na-Phosphate (pH 7.5), 0.15 M NaCl, 1% Triton X-100, 1 mM PMSF, 5 g/ml leupeptin, 5 g/ ml pepstatin, 0.02% NaN 3 , and 1 mM iodoacetamide. Cell lysates were cleared by centrifugation at 13,000 rpm for 20 min, and the supernatant was used for coprecipitation and immunoblot analysis. Non-labeled Jurkat cell lysates were also similarly prepared. The reaction mixtures were precipitated with Ni-NTA resin, as previously described (43) . The precipitates were separated on 12% SDS polyacrylamide gels, and the gels were then fixed, dried, and autoradiographed. For Western blot analysis, HisCytKIR was mixed with Jurkat cell lysates in the presence of DSP, and incubated for 1 hr at room temperature. The reaction mixtures were precipitated with Ni-NTA resin, and washed three times. Precipitates were resolved by SDS-PAGE using 12% acrylamide gels, and proteins were transferred onto polyvinylidene difluoride (PVDF) membranes (Immobilon-P; Millipore, Marlborough, MA). Western blot analysis was performed with anti-Shc antibody, antiGrb2 antibody, and anti-phosphotyrosine antibody, as previously described (43) . In vitro phosphorylation of His-CytKIR. Jurkat cell lysates and the His-CytKIR protein were mixed and incubated in a kinase reaction buffer, as previously described (43) . After in vitro phosphorylation, the His-Cyt KIR was precipitated with Ni-NTA resin. The precipitates were resolved on SDS PAGE gels, and the gels were blotted onto PVDF membranes and analyzed with anti-Grb2, anti-Shc and anti-phosphotyrosine antibodies.
Immunofluorescence staining and Confocal Microscopy. Cells transfected with the pCD8T or pCD8-KIR cDNA were grown on sterile glass coverslides precoated with 1% gelatin overnight prior to antibody staining. 36 hr after transfection, cells were fixed with ice-cold methanol and aceton for 10 min each and incubated with 3% H 2 O 2 for 30 min at room temperature. The coverslides were washed three times with PBS and incubated with blocking solution (5% BSA, 3% normal horse serum, 0.3% Tritonx-100 in PBS) for 3 hr. The cells were simultaneously stained by incubating them with anti CD8 antibody ascites (1 100) followed by a goat antiserum against mouse IgG coupled to FITC and rabbit anti-Shc antibody followed by a goat antiserum against rabbit IgG coupled to Texasred at 37 o C for 2 3 hr and then washed 4 times in PBS. After 3 additional washes in PBS, the slides were mounted in mounting solution. Cells were viewed by confocal microscope (Lica PCSMT, Heidelberg, Germany) using the 100× objective lens. Immunoprecipitation and Western blotting. 293T cells transfected with CD8T or CD8-KIR were stimulated with OKT8 ascites (1 200 dilution). After 30 min stimulation, the cells were rinsed twice with ice-cold PBS and lysed in a lysis buffer (10 mM Tris, pH 7.5, 1% Triton X-100, 150 mM NaCl, 10 mM Na 3 VO 4 , 1 mM NaF, 1 mM Na pyrophosphate, 5 mM EDTA, 50 g/ml leupeptin, 1 U/ml aprotinin, 1 mM pepstatin, 1 mM PMSF). Samples were incubated for 1hr at 4 and twice with 10 mM Tris (pH 7.5) containing 50 mM NaCl and 0.1% triton X-100. After SDS PAGE, the proteins were transferred onto PVDF membrane, and blotted with anti-His-CytKIR antibodies. The membrane was reprobed with anti-SHP-2 antibody. A reciprocal immunoprecipitation experiment was also carried out with anti-His-CytKIR antibodies followed by immunoblotting with anti-Shc antibody and subsequently with anti-SHP-2 antibody.
Results
The cytoplasmic tail of KIR associates with Shc, Grb2, TCRand a protein of 36 kDa in Jurkat T cell lysates. Coaggregation of an activating receptor, such as TCR or FcR, and KIR is required for the inhibition of NK or T cell activation (46, 47) , implying that the inhibitory effect mediated by KIR may occur in the immediate vicinity of the activating receptor. We first asked whether the cytoplasmic tail of KIR interacts with signaling molecules that are also associated with activating receptors, such as TCR, BCR and FcR. To identify proteins associated with the cytoplasmic tail of KIR, we generated a His-tag fusion protein of the cytoplasmic tail (His-CytKIR, Fig. 1A ) and used this fusion protein to co-precipitate proteins from metabolically-labeled Jurkat T cells. Ni-NTA resin was used to coprecipitate proteins interacting with the His-CytKIR. In Jurkat cell lysates, the cytoplasmic tail of KIR coprecipitated the proteins of 46 kDa, 36 kDa, 23 kDa and 16 kDa (Fig. 2A, lane 2) . The coprecipitates appeared as higher Mr (50 100 kDa) complexes under nonreducing conditions ( Fig. 2A, lane 3) , suggesting that the four proteins are really cross-linked to His-CytKIR by DSP, a disulfide containing cross-linker. A control His-tag protein expressed from the pRSETA expression plasmid per se did not result in any detectable proteins coprecipitated in the cell lysates (Fig. 2A, lane 1) The CD8 fusion protein constructs. The generation of plasmid containing the extracellular and transmembrane portion of CD8 , pCD8T, was described previously (44) . A CD8 fusion construct of KIR was generated by subcloning the cytoplasmic tail of KIR into eucaryotic expression vector, pH APr-1 (45). 
His-tag fusion Constructs
Phosphorylated KIR cytoplasmic tail binds SHP-1 and Shc in Jurkat T cell lysates.
To investigate the effect of tyrosine phosphorylation on the molecular association between KIR and the signaling molecules, we carried out similar His-tag pull-down experiments. Metabolically-labeled Jurkat cell lysates were mixed with HisCytKIR in a kinase reaction buffer and incubated at 37 o C as previously described (42, 43) . The reaction mixtures were chemically cross-linked and precipitated with Ni-NTA resin. The precipitates were separated on a SDS polyacrylamide gel and the protein bands were visualized by autoradiography. Unlike the unphosphorylated His-CytKIR ( Fig. 2A) , the phosphorylated His-CytKIR was associated with the 68 kDa and 46 kDa proteins (Fig. 3A) , which turned out to be SHP-1 and Shc, respectively, by Western blot experiments (data not shown). These results are consistent with previous reports showing that the pho- sphorylated KIR recruits SHP-1 (21) (22) (23) (24) 31) , and that the synthetic peptide representing the phosphorylated form of the ITIM of Fc RIIB binds Shc (50) . Previous studies have also shown that Shc associates with tyrosine phosphorylated TCR and Grb2 (51) in T cells, both of which also appeared to associate with KIR in this report. However, in contrast to TCR (43) and Grb2 (Fig. 3B, middle) , Shc appeared to associate with both phosphorylated (Fig. 3B, top, lane  3) and non-phosphorylated His-CytKIR (lane 2). As well, Shc binding was most prominent among the proteins associating with His-CytKIR (Fig. 2A) . These findings suggest that Shc directly associates with His-CytKIR, not through the TCR or Grb2.
Interaction of KIR and Shc in transfected cells.
To verify the association of KIR and Shc in cells, a CD8 fusion protein construct of KIR cytoplasmic tail (CD8-KIR, Fig. 1B ) was transfected into 293T cells. FACS staining with a monoclonal antibody to CD8 (OKT8) and Western blot analysis with polyclonal antibodies to the His-CytKIR protein showed that CD8-KIR was expressed on the surface of 293T cells (Fig. 4A, B , respectively). We next investigated whether the CD8-KIR expressed on 293T cells interacts with Shc. The transfected cells were double stained with anti-Shc antibody and OKT8, and then observed on a confocal microscope. Most of the transfected cells abundantly expressed CD8-KIR, and the CD8-KIR appeared to be localized predominantly on the cell surface (Fig. 4D) . In 293T cells, Shc protein was found in the cytoplasm as well as around the plasma membrane (Fig. 4E) . However, in 293T cells transfected with the CD8-KIR expression vector, most of Shc appeared to be localized around the plasma membrane (Fig. 4C) . Double staining of the transfected cells clearly showed that CD8-KIR and Shc were colocalized on the membrane (Fig. 4F) , suggesting that the two proteins associate in the mammalian cells.
The binding interaction between the CD8-KIR and Shc in transfected cells was confirmed by coimmunoprecipitation analysis. Shc was immunoprecipitated with anti-Shc antibody, and the precipitates were resolved on a SDS polyacrylamide gel. The protein bands were transferred onto PVDF membrane, and sequentially blotted with anti-His-CytKIR antibody and anti-SHP-2 antibody, respectively. Fig. 5A shows that CD8-KIR coprecipitated with Shc (Fig. 5A, top, lane  3) . Interestingly, however, the association was almost blocked when the CD8-KIR was cross-linked by OKT8 antibody prior to the anti-Shc immunoprecipitation (lane 4). On the other hand, SHP-2 binding was only observed when the transfectants were treated with OKT8 antibody cross-linking (Fig. 5A, bottom, lane 4) . The weak intensity of the SHP-2 band may result from the fact that most of the phosphorylated KIR could not precipitate with Shc. Immunoprecipitation with anti-His-CytKIR antibodies and immunoblotting experiments with anti-Shc and anti-SHP-2 antibodies resulted in similar results (Fig. 5B ). Shc coprecipitated with CD8-KIR and the association was greatly reduced by OKT8 antibody cross-linking (Fig. 5B, top) . Both the 46 kDa and 52 kDa forms of Shc appeared to associate with the CD8-KIR in transfected cells. However, SHP-2 binding was not detected in this case (Fig. 5B, bottom) , probably due to the antibody blocking effect. Taken together, these results indicate that CD8-KIR constitutively interacts with Shc in 293T cells but the Shc is replaced by SHP-2 upon engagement of CD8-KIR.
Discussion
By in vitro coprecipitation experiments, we demonstrated that the cytoplasmic tail of KIR associates with proteins of 46 kDa, 36 kDa, 23 kDa, and 16 kDa in Jurkat T cell lysates. Previously, we identified that the 16 kDa protein is TCR and demonstrated that the association between KIR and TCR is hindered by the tyrosine phosphorylation of KIR, but is independent of the tyrosine phosphorylation of the TCR -chain (43) . In this report, we identified that the 46 kDa and 23 kDa proteins are Shc and Grb2, respectively, by immunoblotting experiments. Like the case of TCR , tyrosine phosphorylation of the KIR cytoplasmic tail abolished the association with Grb2 and the 36 kDa protein in Jurkat cell lysates. However, the interaction between KIR and Shc ap- A B peared to be unaffected in vitro. The relatively weak band intensity of Grb2 ( Fig. 2A) and previous reports, where Grb2 appears to associate with Shc, TCR , and LAT (51), suggest that Grb2 may be coprecipitated with other proteins. We also demonstrated that tyrosine phosphorylated KIR associates with SHP-1 and Shc in Jurkat T cell lysates, suggesting that the molecular interaction between KIR and the signaling molecules identified in this study are differently modulated by the phosphorylation status of KIR.
To investigate the molecular interaction between KIR and Shc in cells, we transfected the CD8-KIR expression vector in 293T cells. Double staining of the transfectants with anti-Shc antibody and OKT8 antibody revealed that CD8-KIR and Shc are colocalized around the plasma membrane, and immunoprecipitation analysis confirmed that CD8-KIR binds Shc in transfected cells. In contrast to the in vitro data, however, KIR interacts with Shc in a phosphorylation-dependent manner in cells. Shc binds to CD8-KIR in resting cells, but dissociates in OKT8 treated-cells. Upon engagement of CD8-KIR with OKT8 antibody, KIR appears to associate with SHP-2 instead of Shc, suggesting that the phosphorylation of tyrosine residues in the KIR cytoplasmic tail hinders Shc binding and induces SHP-2 (maybe SHP-1 in NK and T cells) binding in 293T cells where no SHP-1 is expressed (our unpublished observation). The in vitro association of Shc with the phosphorylated KIR may be caused by either incomplete phosphorylation of KIR or excess use of KIR for the in vitro coprecipitation experiments. Also, the association between KIR and Grb2 observed in in vitro experiments was not detected in transfection analysis. This result suggests that Grb2 may be coprecipitated with TCR or the 36 kDa protein which are not expressed in 293T cells but are present in Jurkat T cells. Shc is composed of three different domains, a phospho-tyrosine binding domain (PTB), collagen homolog domain (CH), and SH2 domain (36) (37) (38) . Our data demonstrate that unphosphorylated KIR binds to Shc, but the KIR Shc complex dissociates upon tyrosine phosphorylation of KIR, suggesting that Shc may bind around the ITIMs of KIR. This is quite distinct from the common binding modes of the SH2 and PTB domains, which bind only with phosphorylated tyrosine sites. As well, the CH domain is known to bind with Grb2 via phosphorylated tyrosine residue. Therefore, the binding mode between KIR and Shc seems to be unique. Interestingly, we have shown that the His-CytKIR binds only the 46 kDa form of Shc in Jurkat cell lysates, while the CD8-KIR and endogenous KIR bind the 46 kDa and 52 kDa forms of Shc in 293T cells and in NK and T cells, respectively. The 46 kDa form is distinct from the 52 kDa form only at the N-terminus, where about 50 amino acid residues are truncated in the 46 kDa form by an alternative translation mechanism (36) . Also, the 66 kDa form of Shc has an additional CH domain at the N-terminus of the 52 kDa form (39) . Taken together, the KIR binding sites on the Shc molecule seems to be located at the N-terminal region.
We demonstrated that the cytoplasmic tail of KIR constitutively associates with Shc in vitro as well as in cells. It would be interesting to investigate the functional implications of this observation. Shc proteins recruited by a variety of activated receptors mediate the activation of the Ras signaling pathway through the complex formation of Grb2 SOS (39, 51, 52) . We investigated whether Shc bound to KIR would also turn on the Ras signaling pathway. However, no direct evidence suggesting that the Ras signaling pathway is activated by overexpressing CD8-KIR in 293T cells was obtained (data not shown). CD8-KIR Shc association was evident, but Shc Grb2 association was not observed in the transfected cells. Furthermore, no MAP kinase activation was observed in the transfectants even after the engagement of CD8-KIR with OKT8 antibody. Recent studies have implied that Shc might send another signal distinct from Ras activation for an anti-apototic pathway (53) , for mitogenesis of fibroblast and Drosophila cells (54, 55) , and for cellular transformation (56) . Interestingly, it has been demonstrated that human cytotoxic T cells that express KIR represent oligoclonally or monoclonally-expanded cell populations (57) . In addition, KIR expressed on T cells has been shown to inhibit the activation-induced cell death of T cells in a ligation-independent manner by blocking FasL induction upon stimulation (9, 12) . Furthermore, KIR expressing clones demonstrated greater forward scatter values by FACS analysis and larger cell sizes by image analysis (12) . These observations suggest that KIR might constitutively transmit a certain signal that affects the cell size and the growth pattern of Jurkat T cells.
